FIELD: medicine.
SUBSTANCE: method involves detecting RNA of conservative area of basic capsid protein of human viral papilloma obtained from papilloma tissue samples taken before treatment and 24-72 h later after the treatment. Then, complementary DNA is exposed using reversed transcription-polymerase chain reaction method. The number of genome equivalents is determined. Their number growing smaller, 10 times and more, the treatment is evaluated as effective one.
EFFECT: wide range of functional applications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTION OF HUMAN PAPILLOMA VIRUS ANTIGEN | 2002 |
|
RU2225614C2 |
| METHOD FOR TREATING BENIGN LARYNGEAL NEOPLASMS | 2006 |
|
RU2309700C1 |
| METHOD FOR TREATING THE CASES OF RESPIRATORY LARYNGEAL AND TRACHEAL PAPILLOMATOSIS | 2002 |
|
RU2217194C1 |
| RECOMBINANT FUSED PROTEIN, PREPARATION FOR IMMUNOTHERAPY BASED ON THEREOF AND METHOD FOR IMMUNOTHERAPY OF RELAPSING LARYNX PAPILLOMATOSIS | 2005 |
|
RU2290204C1 |
| METHOD OF SURGICAL TREATMENT OF RECURRING RESPIRATORY PAPILLOMATOSIS BY ARGON-ENHANCED PLASMA COAGULATION | 2010 |
|
RU2444308C1 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF UTERUS CERVIX DYSPLASIA AND CANCER AND LARYNX PAPILLOMATOSIS AND METHOD OF PROPHYLAXIS AND TREATMENT OF SAID SICKNESSES BASED ON THEREOF | 2001 |
|
RU2196568C1 |
| METHOD OF TREATING RECURRENT RESPIRATORY PAPILLOMATOSIS OF LARYNX WITH SCAR MEMBRANE VOICE PORTION | 2015 |
|
RU2600661C1 |
| METHOD FOR ASSESSING RISK OF DEVELOPING CERVICAL CANCER FORMATION IN FEMALES WITH HUMAN PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2522908C1 |
| METHOD FOR TREATING THE CASES OF LARYNGEAL PAPILLOMATOSIS | 2002 |
|
RU2221611C1 |
| INHALATION PHARMACEUTICAL FORM OF DIINDOLYLMETHANE FOR TREATING DISEASES OF UPPER RESPIRATORY PASSAGES | 2017 |
|
RU2665974C1 |
